Skip to content

Clinical trials

Phase 2 Anemia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 2 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20051
20063
20121
20132
20143
20171
20181
20212
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Groupe Francophone des Myelodysplasies3
GlaxoSmithKline2
Hoffmann-La Roche2
Takeda2
Agios Pharmaceuticals, Inc.1
CSL Behring1
Celgene1
Centre Hospital Regional Universitaire de Limoges1
Forma Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia21
Renal Insufficiency, Chronic7
Myelodysplastic Syndromes6
Anemia, Sickle Cell2
Bone Marrow Diseases2
Primary Myelofibrosis2
Cytopenia1
Fatigue1
Genetic Diseases, Inborn1
Hemosiderosis1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.